Sol-Gel Technologies (SLGL) News Today → Do This Before July 30 2024 To Claim Trump’s Gift (From Wealthpin Pro) (Ad) Free SLGL Stock Alerts $0.80 +0.08 (+11.11%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29, 2024 | americanbankingnews.comSol-Gel Technologies Ltd. (NASDAQ:SLGL) Sees Significant Growth in Short InterestMay 28, 2024 | finance.yahoo.comSol-Gel Announces Receipt of Nasdaq Minimum Price NoticeMay 25, 2024 | americanbankingnews.comHC Wainwright Comments on Sol-Gel Technologies Ltd.'s Q2 2024 Earnings (NASDAQ:SLGL)May 23, 2024 | americanbankingnews.comSol-Gel Technologies Ltd. Expected to Post Q1 2024 Earnings of ($0.16) Per Share (NASDAQ:SLGL)May 20, 2024 | investorplace.comSLGL Stock Earnings: Sol-Gel Technologies Misses EPS, Misses Revenue for Q1 2024May 20, 2024 | globenewswire.comSol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesMay 16, 2024 | globenewswire.comSol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and IsraelMay 11, 2024 | morningstar.comSol-Gel Technologies Ltd SLGLApril 20, 2024 | wsj.comSol-Gel Technologies Ltd.April 1, 2024 | globenewswire.comSol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® CreamMarch 23, 2024 | investing.comSol Gel Technologies Ltd (SLGL)March 16, 2024 | finance.yahoo.comSLGL May 2024 2.500 putMarch 14, 2024 | benzinga.comSol-Gel Technologies: Q4 Earnings InsightsMarch 14, 2024 | finance.yahoo.comSol-Gel Technologies Full Year 2023 Earnings: Revenues Beat Expectations, EPS In LineMarch 14, 2024 | finanznachrichten.deSol-Gel Technologies Ltd.: Sol-Gel Reports Full-Year 2023 Financial Results and Corporate DevelopmentsMarch 13, 2024 | globenewswire.comSol-Gel Reports Full-Year 2023 Financial Results and Corporate DevelopmentsFebruary 28, 2024 | finance.yahoo.comSol-Gel Technologies Ltd. (SLGL) stock forecast and price targetFebruary 22, 2024 | benzinga.comSol-Gel Technologies Stock (NASDAQ:SLGL), Quotes and News SummaryDecember 9, 2023 | markets.businessinsider.comOptimistic Buy Rating for Sol-Gel Technologies on Revolutionary Topical Treatment SGT-610’s Market PotentialNovember 30, 2023 | finanznachrichten.deSol-Gel Technologies Ltd.: Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 StudyNovember 30, 2023 | finance.yahoo.comSol-Gel Technologies Screens First Patient for SGT-610 Phase 3 StudyNovember 28, 2023 | finance.yahoo.comSol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610November 20, 2023 | finance.yahoo.comIs Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Trading At A 24% Discount?November 9, 2023 | msn.comSol-Gel Technologies GAAP EPS of -$0.21 beats by $0.02, revenue of $0.21M misses by $0.48MNovember 9, 2023 | finance.yahoo.comSol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateOctober 31, 2023 | finance.yahoo.comZacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel TechnologiesOctober 10, 2023 | finance.yahoo.comIs Sol-Gel Technologies (NASDAQ:SLGL) In A Good Position To Invest In Growth?August 30, 2023 | finance.yahoo.comSol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceAugust 15, 2023 | msn.comHC Wainwright & Co. Maintains Sol-Gel Technologies (SLGL) Buy RecommendationAugust 11, 2023 | markets.businessinsider.comExpert Ratings for Sol-Gel TechnologiesAugust 10, 2023 | finance.yahoo.comSol-Gel Technologies Ltd. (SLGL) Reports Q2 Loss, Lags Revenue EstimatesAugust 10, 2023 | finance.yahoo.comSol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateJuly 21, 2023 | finance.yahoo.comSol-Gel Technologies Ltd.'s (NASDAQ:SLGL) Top Key Executive Moshe Arkin is the most upbeat insider, and their holdings increased by 15% last weekJuly 20, 2023 | nasdaq.comRaymond James Maintains Sol-Gel Technologies (SLGL) Strong Buy RecommendationJune 6, 2023 | msn.comIsrael's Sol-Gel signs Canadian licensing deal for Twyneo, EposolayJune 5, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Their Buy Rating for Sol-Gel Technologies (SLGL)June 2, 2023 | finance.yahoo.comShareholders in Sol-Gel Technologies (NASDAQ:SLGL) are in the red if they invested five years agoMay 12, 2023 | finanznachrichten.deSol-Gel Technologies Ltd.: Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 12, 2023 | finance.yahoo.comSol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Tops Revenue EstimatesMay 12, 2023 | finance.yahoo.comSol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides Corporate UpdateApril 22, 2023 | finance.yahoo.comCompanies Like Sol-Gel Technologies (NASDAQ:SLGL) Can Afford To Invest In GrowthApril 13, 2023 | msn.comHC Wainwright & Co. Reiterates Sol-Gel Technologies (SLGL) Buy RecommendationApril 12, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Sol-Gel Technologies (SLGL)March 20, 2023 | finance.yahoo.comSol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual ConferenceMarch 20, 2023 | finance.yahoo.comSol-Gel Technologies to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual ConferenceMarch 10, 2023 | finanznachrichten.deSol-Gel Technologies Ltd.: Sol-Gel Reports Full-Year 2022 Financial Results and Corporate DevelopmentsMarch 10, 2023 | finance.yahoo.comSol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Lags Revenue EstimatesMarch 10, 2023 | finance.yahoo.comSol-Gel Reports Full-Year 2022 Financial Results and Corporate DevelopmentsFebruary 28, 2023 | seekingalpha.comSLGL Sol-Gel Technologies Ltd.February 27, 2023 | finance.yahoo.comCould The Market Be Wrong About Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Given Its Attractive Financial Prospects? Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Discover AI Giants? (Ad)Wondering which AI stocks are set to soar in 2024? We’ve identified the top 3, and we're excited to share them with you! Unlock immediate access to our exclusive report and discover... the key players and strategic insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Download Your Free Report Now] SLGL Media Mentions By Week SLGL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLGL News Sentiment▼0.230.77▲Average Medical News Sentiment SLGL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLGL Articles This Week▼40▲SLGL Articles Average Week Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Milestone Pharmaceuticals News Vaccitech News InflaRx News IO Biotech News Chimerix News Oncolytics Biotech News Assembly Biosciences News Marinus Pharmaceuticals News Hillstream BioPharma News Benitec Biopharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLGL) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaHow Biden has already won 2024Porter & CompanyThis unknown company solves the biggest issue with AIManward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
